SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 14D9/A - Solicitation, recommendation statements: [Amend]
SEC Accession No. 0001193125-19-083838
Filing Date
2019-03-25
Accepted
2019-03-22 18:26:33
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 14D9/A d727572dsc14d9a.htm SC 14D9/A 135811
  Complete submission text file 0001193125-19-083838.txt   137801
Mailing Address 601 GATEWAY BOULEVARD SUITE 250 SOUTH SAN FRANCISCO CA 94080
Business Address 1616 EASTLAKE AVENUE E. SUITE 310 SEATTLE WA 98102 (650) 392-8350
IMMUNE DESIGN CORP. (Filed by) CIK: 0001437786 (see all company filings)

IRS No.: 262007174 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 14D9/A
SIC: 2834 Pharmaceutical Preparations

Mailing Address 601 GATEWAY BOULEVARD SUITE 250 SOUTH SAN FRANCISCO CA 94080
Business Address 1616 EASTLAKE AVENUE E. SUITE 310 SEATTLE WA 98102 (650) 392-8350
IMMUNE DESIGN CORP. (Subject) CIK: 0001437786 (see all company filings)

IRS No.: 262007174 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 14D9/A | Act: 34 | File No.: 005-88256 | Film No.: 19700975
SIC: 2834 Pharmaceutical Preparations